Cindy L Schwartz Selected Research

samarium Sm-153 lexidronam (Quadramet)

12/2010	Tandem dosing of samarium-153 ethylenediamine tetramethylene phosphoric acid with stem cell support for patients with high-risk osteosarcoma.
6/2009	Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Cindy L Schwartz Research Topics

Disease

31	Hodgkin Disease (Hodgkin's Disease) 01/2022 - 11/2003
22	Neoplasms (Cancer) 03/2022 - 02/2003
13	Osteosarcoma (Osteogenic Sarcoma) 01/2022 - 01/2002
4	Infections 10/2016 - 01/2002
3	Fever (Fevers) 10/2022 - 01/2010
3	Precursor Cell Lymphoblastic Leukemia-Lymphoma (Acute Lymphoblastic Leukemia) 01/2022 - 09/2007
3	Left Ventricular Dysfunction 01/2019 - 01/2016
3	Cardiotoxicity 01/2019 - 06/2011
3	Leukemia 10/2017 - 09/2007
2	Lymphoma (Lymphomas) 01/2022 - 08/2015
2	Second Primary Neoplasms (Neoplasms, Second) 01/2022 - 08/2015
2	Pleural Effusion (Pleural Effusions) 11/2018 - 03/2009
2	Necrosis 10/2016 - 01/2016
2	Acute Myeloid Leukemia (Acute Myelogenous Leukemia) 08/2015 - 02/2007
2	Myelodysplastic Syndromes (Myelodysplastic Syndrome) 06/2011 - 02/2007
2	Heart Diseases (Heart Disease) 05/2010 - 02/2003
1	Obesity 03/2022
1	Hypertension (High Blood Pressure) 03/2022
1	Dyslipidemias (Dyslipidemia) 03/2022
1	Prehypertension 03/2022
1	Cardiomyopathies (Cardiomyopathy) 01/2022
1	Myocardial Ischemia (Ischemic Heart Diseases) 01/2022
1	Stroke (Strokes) 01/2022
1	Sarcoma (Soft Tissue Sarcoma) 01/2019
1	Heart Failure 01/2019
1	Sclerosis 01/2018
1	Lymphadenopathy 12/2017
1	Infarction (Infarctions) 10/2016
1	Neoplasm Metastasis (Metastasis) 10/2016
1	Fatigue 09/2015
1	Lung Neoplasms (Lung Cancer) 05/2010
1	Non-Hodgkin Lymphoma (Lymphosarcoma) 05/2010
1	Anaphylaxis (Anaphylactic Shock) 02/2010
1	Bacteremia 01/2010
1	Hyperbilirubinemia 03/2009

Drug/Important Bio-Agent (IBA)

11	Doxorubicin (Adriamycin)FDA LinkGeneric 03/2022 - 03/2005
8	Etoposide (VP 16)FDA LinkGeneric 01/2018 - 01/2002
8	Ifosfamide FDA LinkGeneric 01/2017 - 01/2002
6	Dexrazoxane (Zinecard)FDA LinkGeneric 01/2022 - 02/2007
6	Cisplatin (Platino)FDA LinkGeneric 01/2018 - 03/2005
4	Vincristine (Oncovin)FDA LinkGeneric 01/2018 - 03/2006
4	Bleomycin (Blenoxane)FDA LinkGeneric 01/2018 - 03/2006
4	Prednisone (Sone)FDA LinkGeneric 01/2018 - 03/2006
4	Methotrexate (Mexate)FDA LinkGeneric 10/2016 - 03/2005
4	Vinorelbine (Navelbine)FDA LinkGeneric 07/2015 - 03/2009
3	Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link 12/2020 - 12/2010
3	AnthracyclinesIBA 01/2019 - 06/2011
2	AlbuminsIBA 10/2022 - 01/2017
2	Cytarabine (Cytosar-U)FDA LinkGeneric 01/2018 - 03/2006
2	Cyclophosphamide (Cytoxan)FDA LinkGeneric 01/2018 - 12/2017
2	Samarium-153IBA 12/2010 - 06/2009
2	samarium Sm-153 lexidronam (Quadramet)FDA Link 12/2010 - 06/2009
2	Gemcitabine FDA Link 11/2010 - 03/2009
2	Mechlorethamine (Nitrogen Mustard)FDA Link 06/2006 - 03/2006
2	Procarbazine (Matulane)FDA Link 06/2006 - 03/2006
2	Vinblastine (Vinblastine Sulfate)FDA Link 06/2006 - 03/2006
2	Dacarbazine (DIC)FDA LinkGeneric 06/2006 - 03/2006
1	pro-brain natriuretic peptide (1-76)IBA 01/2019
1	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2019
1	Indicators and Reagents (Reagents)IBA 11/2018
1	Dexamethasone (Maxidex)FDA LinkGeneric 01/2018
1	Immunoglobulin D (IgD)IBA 01/2018
1	Dihydrotachysterol (AT 10)IBA 10/2017
1	Cell-Free Nucleic AcidsIBA 04/2017
1	DNA (Deoxyribonucleic Acid)IBA 04/2017
1	microbial alkaline proteinase inhibitor (MAPI)IBA 01/2016
1	Bortezomib (Velcade)FDA Link 07/2015
1	Insulin (Novolin)FDA Link 04/2014
1	Insulin-Like Growth Factor Binding Protein 2IBA 04/2014
1	Insulin-Like Growth Factor Binding Protein 3IBA 04/2014
1	Insulin-Like Growth Factor I (IGF-1)IBA 04/2014
1	RadiopharmaceuticalsIBA 12/2010
1	ethylenediamine (ethylenediamine dihydroiodide)FDA Link 12/2010
1	phosphoric acid (orthophosphoric acid)FDA Link 12/2010
1	LipidsIBA 05/2010
1	pegaspargase (Oncaspar)FDA Link 02/2010
1	Asparaginase (Elspar)FDA Link 02/2010
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2010
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 01/2010
1	phosphonic acidIBA 06/2009
1	EnzymesIBA 03/2009
1	Pharmaceutical PreparationsIBA 02/2008
1	EchinocandinsIBA 10/2007
1	Monoclonal AntibodiesIBA 05/2007
1	ParaffinIBA 05/2007
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 05/2007
1	Alkylating AgentsIBA 03/2006

Therapy/Procedure

25	Therapeutics 01/2022 - 01/2002
22	Drug Therapy (Chemotherapy) 01/2021 - 01/2002
11	Radiotherapy 01/2022 - 06/2006
3	Induction Chemotherapy 10/2016 - 01/2002
2	Aftercare (After-Treatment) 09/2015 - 11/2010
1	Heart Transplantation (Grafting, Heart) 01/2022
1	Neoadjuvant Therapy 01/2017
1	Stem Cell Transplantation 01/2015
1	Combined Modality Therapy 05/2011
1	Remission Induction 02/2010
1	Central Venous Catheters 01/2010
1	Catheters 01/2010
1	Chemoradiotherapy 06/2006